This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA). The single-award, firm fixed-price delivery order is valued at $2,960.00 and has an ultimate completion date of September 26, 2024.
DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical centers nationwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items. Through this vehicle, DMS Pharmaceutical Group delivers both routine and critical medications to support the diverse medical requirements of the Department of Defense healthcare system.
Generated 12/5/24, 10:37 AM